Europe
United Kingdom
Europe
United Kingdom

The 'go to' European specialist pharma company

Dantrium IV

Dantrium Intravenous, 20mg dantrolene sodiumDantrium IV packaging

 

Licensed in the UK for the treatment of malignant hyperthermia

 

The links below will redirect you to an alternative site not maintained by Norgine Pharmaceuticals Limited

 

View the Patient Information Leaflet

View the Summary of Product Characterisitics

 

Please consult with your Doctor, or other qualified Healthcare Professional before use.

 

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

 

By reporting side effects you can help provide more information on the safety of this medicine.